A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

NCT06605703 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

BEHAVIORAL: WW Clinic
DRUG: Bupropion-Naltrexone
DRUG: Bupropion-Naltrexone-Metformin

Sponsor

WW International Inc